Right! If MDT is going to pay up for TMDI they are going to want to make sure they take as much risk off the table (ie milestones completed, validation) as possible.
In my opinion, which is worth less then .25, they will acquire TMDI after human trials are successful (their timing). IMO, FDA won't be a problem for various reasons already stated.
I've spoken about this before but if this reasoning/scenario is somewhat accurate, it's why I believe a BO will be in the $3B area, otherwise, TMDI would have probably agreed to a BO instead of a partnership out of the gate. Think about it ppl, MDT would have been more then willing to risk $1B up front but TMDI wasn't willing. All speculation of course. GL longs!
News 
Market Data 
Discover 
AI
